Ownership history in SUVRETTA CAPITAL MANAGEMENT, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which SUVRETTA CAPITAL MANAGEMENT, LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 4,139,426 | +1,261,426 | +43.8% | 2.13% | $104.0M | $25.12 |
| 2025 Q3 | UNCHANGED | 2,878,000 | — | 0% | 1.67% | $65.1M | $22.63 |
| 2025 Q2 | ADDED | 2,878,000 | +1,231,385 | +74.8% | 1.50% | $49.8M | $17.31 |
| 2025 Q1 | ADDED | 1,646,615 | +853,428 | +107.6% | 1.34% | $36.0M | $21.87 |
| 2024 Q4 | ADDED | 793,187 | +771,587 | +3572.2% | 0.86% | $25.3M | $31.91 |
| 2020 Q1 | INITIATED | 21,600 | — | — | 0.02% | $579K | $26.79 |
As of 2025 Q4 — sorted by position size